{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-107259","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2024-09-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.002110+00:00","generated_at":"2026-05-31T04:17:16.422057+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Crinetics CCO James Hassard to depart effective October 14, 2024","bullets":["James Hassard separates as Chief Commercial Officer; last day October 14, 2024.","Hassard will receive severance per Employment Agreement for termination without cause, subject to release.","No replacement for CCO role announced by Crinetics."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-107259","json":"https://secwatch.observer/filing/0000950170-24-107259.json","markdown":"https://secwatch.observer/filing/0000950170-24-107259.md","text":"https://secwatch.observer/filing/0000950170-24-107259.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024107259/0000950170-24-107259-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024107259/crnx-20240913.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T04:17:16.422057+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7d1b03e652","claim":"James Hassard departed as Chief Commercial Officer at Crinetics Pharmaceuticals, Inc..","evidence_excerpt":"On September 13, 2024, Crinetics Pharmaceuticals, Inc. (the “Company”) determined that James Hassard will separate from the Company and will cease serving as the Chief Commercial Officer, effective October 14, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1658247/000095017024107259/0000950170-24-107259-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}